SCHEMBL19904403

SCHEMBL19904403

Cc1cc(CCCN=O)ccc1OC1CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 2/20 0.36
RECQL P46063 1/20 0.36
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
PDE4B Q07343 1/20 0.34
HRH1 P35367 2/20 0.34
CCR3 P51677 2/20 0.34
FFAR4 Q5NUL3 3/20 0.34
CSNK2A1 P68400 2/20 0.34
GAA P10253 2/20 0.34
MAPK1 P28482 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34
KCNH2 Q12809 1/20 0.34
FFAR1 O14842 2/20 0.33
S1PR1 P21453 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10260908 0.83 CSNK2A1 (0.34) PDE4BCSNK2A1FFAR1
SCHEMBL18634962 0.80 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AMAPTRECQL
SCHEMBL23731761 0.76 FFAR4 (0.41) ALDH1A1HRH1FFAR4TSHR
SCHEMBL21122862 0.76 ABCB1 (0.46) ALDH1A1RECQLHRH1
SCHEMBL19904683 0.76 SIGMAR1 (0.38) ALDH1A1MEN1KMT2AMAPTRECQL
SCHEMBL24045454 0.76 HRH1 (0.47) ALDH1A1RECQLHRH1KCNH2SMN1; SMN2
SCHEMBL18634973 0.74 HDAC1 (0.44) MEN1KMT2AHPGDFFAR4KCNH2
SCHEMBL19904660 0.72 HRH3 (0.46) MAPTPDE4BKCNH2CRHBPCRHR2
SCHEMBL22737939 0.71 ATM (0.56) SMN1; SMN2
SCHEMBL22693870 0.69 SYK (0.48) RECQLPDE4BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed